Cas No : 94790-37-1
Molecular formula : C11H16F6N5OP
Melting point : 200 °C (dec.)(lit.)
Flash point : 200°C
Storage : Store at +2°C to +8°C.
PH: 4.1 (1.6g/l, H2O)
Decomposition : 200 ºC
BRN : 7328329
Application : Condensation agent for peptide synthesis . The coupling agent for peptide synthesis has the following advantages: very low racemization, simple reaction conditions, short reaction time and high yield; The latest research shows that the crystal and solution structure of the coupling agent is guanidine salt N-oxide rather than urea cationic compound . Some studies have shown that HBTU is guanidine positive ion rather than urea positive ion in both crystal and solution state. When used as polypeptide condensation agent, HBTU has the advantages of very low racemization probability, simple reaction conditions and short reaction time, so it is considered as a high yield .
We are Princechem Pharmaceutical manufacturer pass 20 years experience. Types of chemical reactions in are etherification, ammoniation, chlorination, esterification, cyclization, hydrogenation and Grignard reaction, etc..Over the past 10 years, more than 400 catalog products were developed. In recent years, more than 40 kinds of key pharmaceutical intermediates have been developed, involving anti-cancer, cardiovascular, digestive system, mental diseases and other fields. It includes the key intermediates of API such as Quetiapine, Fluvaxamine, Erlotinib, Gefitinib, Sunitinib, Lapatinib, Rabeprazole and Lafutidine. For many years, we have been providing high quality pharmaceutical intermediates for many world-famous pharmaceutical companies.
HI-Tech Enterprise was honored to YPC in 2011. The company adheres to scientific and technological innovation and has more than 10 authorized invention patents.
YPC insists on using the international standard management systems to promote our managements and have established the systems of ISO9001:2000, ISO14001:2004 and OHS18001:1999. Over the past few years, it has passed on-site audits by more than 20 international and domestic pharmaceutical companies.